Literature DB >> 2115629

Interaction of intravenous methylprednisolone with oral cyclosporin.

C S Ubhi1, L Woodhouse, G R Giles.   

Abstract

The plasma cyclosporin values during 17 consecutive rejection episodes in 13 renal allograft recipients have been monitored by high-performance liquid chromatography and radioimmunoassay. In response to anti-rejection therapy with intravenous methylprednisolone, there was a significant increase of greater than 100 ng/ml on only three occasions. We suggest that elevated cyclosporin values during rejection episodes should not be dismissed as the result of steroid therapy and that the original diagnosis must be reviewed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2115629     DOI: 10.1093/ndt/5.5.376

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  2 in total

1.  Explaining variability in ciclosporin exposure in adult kidney transplant recipients.

Authors:  Rogier R Press; Bart A Ploeger; Jan den Hartigh; T van der Straaten; Hans van Pelt; Meindert Danhof; Hans de Fijter; Henk-Jan Guchelaar
Journal:  Eur J Clin Pharmacol       Date:  2010-03-31       Impact factor: 2.953

2.  Sirolimus steady-state trough concentrations are not affected by bolus methylprednisolone therapy in renal allograft recipients.

Authors:  L Bäckman; H Kreis; J M Morales; H Wilczek; R Taylor; J T Burke
Journal:  Br J Clin Pharmacol       Date:  2002-07       Impact factor: 4.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.